Skip to main content
. Author manuscript; available in PMC: 2008 Jun 1.
Published in final edited form as: Neurobiol Dis. 2007 Mar 24;26(3):688–695. doi: 10.1016/j.nbd.2007.03.006

Figure 6.

Figure 6

Quantification of the protective effect of Ad-GFAP-HO-1. Mean culture percentage LDH release (left axis) and percentage cell viability (right axis) as assessed by MTT assay (± SEM, n = 7–10/condition), 24 hours after treatment with 10 μM hemin, preceded by 24 hour treatment with 100 MOI Ad-GFAP-HO-1 or 100 MOI control Ad-Null. ***P < 0.001, unpaired two-tailed t test.